Arrakis Therapeutics

Arrakis Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $75M
Latest Deal Amount
  • Investors
  • 14

Arrakis Therapeutics General Information

Description

Developer of a drug discovery platform intended to target RNA. The company's platform integrates leading-edge RNA bioinformatic and structural tools to produce a pipeline of rSMs to treat a range of disease including neurology, oncology and rare genetic diseases, enabling physicians to offer enhanced care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 830 Winter Street
  • Waltham, MA 02451
  • United States

Arrakis Therapeutics Timeline

2017201820192020
Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Arrakis Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 10-Apr-2019 $75M 00000 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 02-Mar-2017 000.00 000.00 0000 Completed Generating Revenue

Arrakis Therapeutics Cap Table

To view Arrakis Therapeutics‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000

Arrakis Therapeutics Competitors (64)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Amunix Private Equity-Backed Mountain View, CA 00 000.00 0000000 0000 000.00
0000000000000 Corporation Shelton, CT 00 000.00 000000000 000.00
0000 Venture Capital-Backed Emeryville, CA 00 00000 00000000000 00000
00000 000000000000 Formerly VC-backed San Francisco, CA 00 00000 000000000 00000
000000000 Formerly VC-backed Tucson, AZ 00 000.00 000000&0 000.00

Arrakis Therapeutics Executive Team (9)

Name Title Board Seat Contact Info
Jennifer Petter Ph.D Co-Founder & Chief Scientific Officer
Daniel Koerwer Chief Business Officer
Alan Walts Ph.D Co-Founder & Board Member
James Barsoum Ph.D Senior Vice President of Biology
Heather Lounsbury Vice President of Business & Technical Operations

1 Former Executive

Arrakis Therapeutics Board Members (13)

To view Arrakis Therapeutics‘s full board member team, request access »
Name Representing Role Since
Alan Walts Ph.D Arrakis Therapeutics Co-Founder & Board Member 000 0000
Carolyn Green Self Board of Director 000 0000
Colleen Cuffaro Ph.D Canaan Partners Board of Director 000 0000
Elaine Jones Ph.D Pfizer Ventures Board Observer & Board Member 000 0000
Jakob Loven Ph.D Nextech Invest Board Member 000 0000

Arrakis Therapeutics Investors (14)

To view Arrakis Therapeutics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
GV Corporate Venture Capital Minority 000 0000 000000 0
HBM Healthcare Investments Venture Capital Minority 000 0000 000000 0
HBM Partners Venture Capital Minority 000 0000 000000 0
Nextech Invest Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial